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Abstract
NR5A1 is the key regulator of adrenal and gonadal development in both humans and mice. Recently, a missense
substitution in human NR5A1, p.R92W, was shown to underlie gonadal dysgenesis in genetic males and testicular
formation in genetic females. Here, we investigated the phenotypic effects of the p.R92W mutation on murine
development. Mice carrying the p.R92W mutation manifested a similar but milder phenotype than that of the
previously described Nr5a1 knockout mice. Importantly, mutation-positive XX mice showed no signs of
masculinization. These results, together with prior observations, indicate that the p.R92W mutation in NR5A1/Nr5a1
encodes unique molecules that disrupt male gonadal development in both humans and mice and induces
testicular formation specifically in human females. Our findings provide novel insights into the conservation and
divergence in the molecular networks underlying mammalian sexual development.
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Introduction
Nuclear receptor subfamily 5 group A member 1
(NR5A1) plays a critical role in the development of the
adrenal gland and gonad in human [1, 2]. Heterozygous
loss-of-function mutations in NR5A1 account for a cer-
tain percentage of the etiology of gonadal dysgenesis in
46,XY individuals and a small fraction of the genetic
causes of ovarian insufficiency in 46,XX individuals
[1–3]. NR5A1 mutations rarely underlie adrenal insuf-
ficiency, indicating that during human development,
gonads are more vulnerable than adrenal glands to
the reduced NR5A1 activity [1, 2]. Recently, Basham-
boo et al. identified a heterozygous missense mutation
in NR5A1, p.R92W (c.274C > T), in four unrelated
patients with 46,XX testicular/ovotesticular disorders
of sex development (DSD) [4]. This mutation affects
a highly conserved amino acid in the DNA binding
domain of the wild-type (WT) NR5A1 protein. These
findings provide the first indication that specific
NR5A1 mutations can switch the developmental pro-
cesses of immature 46,XX gonads toward testicular
formation. Since Bashamboo et al. identified p.R92W
in two phenotypically normal mothers of patients and
a 46,XY sibling with female-type external genitalia [4],
this mutation seems to be associated with a broad pheno-
typic spectrum. Subsequently, the same mutation was
identified in additional 46,XX DSD patients [5, 6].
Murine NR5A1 has 94 % amino acid homology with
human NR5A1 and is involved in adrenal and gonadal
development [1, 2, 7, 8]. Homozygous Nr5a1 knockout
(Nr5a1−/−) mice lack the adrenal gland and gonad and
die within 8 days after birth [7, 8]. Heterozygous
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knockout (Nr5a1WT/−) mice are viable and show no ap-
parent abnormalities, except for mildly compromised
glucocorticoid secretion and relatively small testes and
ovaries [8, 9]. These observations imply that NR5A1
plays similar roles in humans and mice, although there
are some inter-species differences in the functions of this
protein in various tissues. Thus, it remains unknown
whether the p.R92W mutation affects sexual develop-
ment in mice.
Genome-editing is a new technology that enables
researchers to introduce specific nucleotide substitu-
tions into the genome [10]. This technology is useful
to create animal models of human disorders. In our
previous study, we performed genome-editing to gen-
erate mice carrying the p.R92W mutation of Nr5a1
[10]. Here, we analyzed phenotypic characteristics of
homozygous (Nr5a1p.R92W/p.R92W) and heterozygous
(Nr5a1WT/p.R92W) mice with this mutation.
Materials and methods
Animal treatment
This study was approved by the Animal Care Committee
at the National Research Institute for Child Health and
Development (project number: A2016-002). All experi-
ments were performed in accordance with the institu-
tional guidelines of the care and use of laboratory
animals.
Generation of mice carrying the p.R92W substitution
Prior to this study, we introduced the p.R92W mutation
into the murine genome using the CRISPR/Cas9 system
[10]. In brief, guide RNAs, hCas9 mRNA, and single-
stranded donor oligonucleotides were injected into
BDF1 zygotes. The cytosine at the 274th position was
successfully substituted to a thymine. Mice were geno-
typed by PCR sequencing using genomic DNA samples
extracted from tail tips.
Phenotypic analysis of mice carrying the p.R92W
substitution
Mutation-positive mice of two separate lines were back-
crossed to the C57BL/6N strain for at least five genera-
tions. Mice of the fifth or sixth generations were
analyzed in this study. Their age-matched WT litter-
mates were used as controls. We examined external
genitalia of homozygous (Nr5a1p.R92W/p.R92W, n = 100)
and heterozygous (Nr5a1WT/p.R92W, n = 100) fetal and
neonatal mice. Since homozygosity of the p.R92W muta-
tion resulted in early postnatal death, we performed
cesarean section at 18.5 days post-coitum (dpc) to obtain
tissue samples from Nr5a1p.R92W/p.R92W mice. Urogenital
organs and adrenal glands of the fetuses were subjected
to morphological analyses, and gonads were analyzed
histologically (46,XX, n = 3; 46,XY, n = 3). We also
histologically examined gonads obtained from fetuses
shortly after sex determination (at 13.5 dpc; 46,XX,
n = 3; 46,XY, n = 3).
In addition, we obtained adrenal glands and gonads
from Nr5a1WT/p.R92W mice at 8 weeks of age. These
tissues were weighed and subjected to morphological
analyses. Statistical differences in the mean values be-
tween the two groups were examined by Student’s t test
or Mann-Whitney’s U test. P values of less than 0.05
were considered significant. Subsequently, the tissues
were sectioned, stained with hematoxylin-eosin, and an-
alyzed histologically.
Results
Phenotypic analysis of mice carrying the p.R92W
substitution
Mutation-positive mice from the two lines showed iden-
tical phenotypes. Nr5a1p.R92W/p.R92W mice were born
alive, but died within the first 1 week after birth.
Nr5a1p.R92W/p.R92W mice had female-type external geni-
talia, regardless of karyotype (Fig. 1). Adrenal glands
were absent (Fig. 1). Nr5a1p.R92W/p.R92W XY mice mani-
fested hypoplastic gonads in the intra-abdominal region,
whereas Nr5a1p.R92W/p.R92W XX mice had gonads of nor-
mal or slightly reduced sizes (Fig. 1). Histological ana-
lyses revealed that while the testicular cords were
recognizable in the gonads of WT XY mice at 13.5 and
18.5 dpc, such structures were not apparent in the go-
nads of Nr5a1p.R92W/p.R92W XY mice at both stages
(Fig. 2). There were no noticeable differences in gonadal
histology between Nr5a1p.R92W/p.R92W and WT XX mice
at 13.5 and 18.5 dpc (Fig. 2).
Nr5a1WT/p.R92W mice were healthy and virtually indis-
tinguishable from the WT littermates. Nr5a1WT/p.R92W
mice of both sexes showed karyotype-matched external
genitalia and were fertile. However, Nr5a1WT/p.R92W
mice at 8 weeks of age showed somewhat smaller
adrenal glands than those of WT animals (Fig. 3a, b).
Furthermore, testicular size was mildly reduced in
Nr5a1WT/p.R92W XY mice, whereas ovarian size was
comparable between Nr5a1WT/p.R92W and WT XX mice
(Fig. 3a, b). Testes and ovaries of Nr5a1WT/p.R92W mice
were histologically unremarkable (Fig. 3a).
Discussion
We investigated the phenotypic characteristics of mice
carrying the p.R92W mutation in Nr5a1, an orthologous
substitution of a unique human mutation that underlies
gonadal dysgenesis in 46,XY patients and testicular for-
mation in 46,XX patients [4–6]. The phenotypes of
mutation-positive mice were similar but slightly milder
than those of the previously reported Nr5a1−/− mice
[1, 2, 7, 8]. Indeed, Nr5a1p.R92W/p.R92W mice exhibited
hypoplastic gonads and a lack of adrenal glands. Neonatal
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Fig. 1 Morphological findings of wild-type (WT) and Nr5a1p.R92W/p.R92W mice. Urogenital organs obtained from XY and XX mouse fetuses at
18.5 days post-coitum. Broken circles and white arrowhead indicate the positions of adrenal glands and gonads, respectively. Black arrowheads
depict the ano-genital distance. Scale bars, 1 mm
Fig. 2 Histological findings of wild-type (WT) and Nr5a1p.R92W/p.R92W mice. Gonads obtained from XY and XX mouse fetuses at 13.5 days post-
coitum (dpc) (a) and at 18.5 dpc (b). Enlarged images are shown in the lower panels. Black-dashed lines indicate the testicular cords. G gonad,
M mesonephros. Single-stranded scale bars, 100 μm; double-stranded scale bars, 50 μm
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death of Nr5a1p.R92W/p.R92W mice can be attributed to
glucocorticoid deficiency, as in the case of Nr5a1−/− mice
[7, 8]. Likewise, adult Nr5a1WT/p.R92W mice had relatively
small adrenal glands and testes compared with those of
the WT animals, although they were healthy and fertile.
Again, these phenotypes were comparable to those in pre-
viously described Nr5a1WT/− mice, which exhibited no
obvious abnormalities except for subnormal gonadal
size and subnormal cortisol production [8, 9]. On the
other hand, our Nr5a1WT/p.R92W and Nr5a1p.R92W/p.R92W
XX mice retained apparently normal ovaries, whereas
Nr5a1WT/− XX mice are known to have undersized ovar-
ies [9]. It appears that the p.R92W mutation exerts a
minor effect on ovarian development.
The present study revealed similarities and differences
in the phenotypic effects of the p.R92W mutation in
humans and mice. In both species, the p.R92W mutation
caused XY gonadal dysgenesis. Defective testicular devel-
opment in genetic males with this mutation is indicative
of the impaired transactivation activity of the mutant
NR5A1 on SOX9/Sox9. Consistent with this, in vitro as-
says have shown that the p.R92W mutant barely transac-
tivates the testis enhancer sequence core element
(TESCO) of Sox9 [4]. In this regard, the p.R92W muta-
tion appears to abolish the NR5A1 function also in the
adrenal gland, as evidenced by the lack of adrenal gland
in Nr5a1p.R92W/p.R92W mice. While mutation-positive hu-
man patients showed no signs of adrenal insufficiency,
the mutation may still impair NR5A1 function in human
adrenal glands because NR5A1 haploinsufficiency usually
permits normal adrenal function in humans [1, 2].
In contrast, the p.R92W mutation did not cause appar-
ent XX testicular DSD in mice. Indeed, Nr5a1p.R92W/
p.R92W XX fetuses showed histologically unremarkable
ovaries at 13.5 and 18.5 dpc. This suggests a functional
difference of the p.R92W mutation between humans and
mice, although the number of gonadal samples analyzed
in the present study was relatively small. Since Basham-
boo et al. identified the p.R92W mutation in both 46,XX
DSD patients and their unaffected mothers [4], this mu-
tation may have low penetrance. Thus, we examined ex-
ternal genitalia of more than 50 Nr5a1WT/p.R92W XX
mice and confirmed that none of these animals had mas-
culinized external genitalia. The discrepancy in ovarian
phenotypes between human patients and mutation-
induced mice may reflect the inter-species differences in
the expression pattern of NR5A1/Nr5a1 in immature
ovaries. Nr5A1 transcripts are barely detectable in the
murine ovary during the critical period for gonadal for-
mation, whereas NR5A1 mRNA is continuously
expressed in the human fetal ovary [4, 11]. It has been
suggested that in the human fetal ovary, NR5A1
Fig. 3 Morphological and histological findings of wild-type (WT) and Nr5a1WT/p.R92W mice. a Gonads and adrenal glands obtained from mice at
8 weeks of age. Enlarged images are shown in the lower panels. C cortex, M medulla. Single-stranded scale bars, 1 mm; double-stranded scale bars,
200 μm. b Weights of gonads and adrenal glands in WT and Nr5a1WT/p.R92W mice at 8 weeks of age. Data are expressed as the mean ± SEM
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activates several anti-testis genes, such as CTNNB and
WNT4 [5], and antagonizes nuclear receptor subfamily 0
group B member 1 (NR0B1) to suppress SOX9 expres-
sion [4, 6]. NR5A1-induced suppression of SOX9 ap-
pears to be essential for the maintenance of normal
ovarian development in humans [4]. It is worth men-
tioning that simple loss-of-function mutations in human
NR5A1 is insufficient to induce testicular development
in genetic females. Indeed, although various nonsense
and frameshift mutations in NR5A1 have been reported
to date [1, 2], none of these mutations caused 46,XX tes-
ticular DSD. Therefore, the p.R92W protein should have
a unique activity that alters the developmental switch of
human immature ovary toward testicular formation. It is
possible that p.R92W affects the expression levels of
anti-testis genes in the developing human ovary [5]. Al-
ternatively, the p.R92W protein may be less sensitive to
NR0B1-induced suppression on SOX9 TESCO compared
to WT NR5A1 [6]. These assumptions need to be vali-
dated in future studies.
In conclusion, the results of this study, in conjunction
with previous observations [4–6], imply that the p.R92W
mutation in NR5A1/Nr5a1 disrupts male gonadal devel-
opment in both humans and mice and induces aberrant
testicular formation specifically in human females. These
findings provide novel insights into the conserved and
species-specific molecular networks underlying mamma-
lian sex development.
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